Pfizer Reports Second-Quarter 2008 Results - Pfizer Inc (NYSE: PFE): -0- See end of text prior to tables for notes.Pfizer Inc (NYSE: PFE) today reported financial results for the second-quarter 2008.
The Company recorded revenues of $12.1 billion, an increase of 9% compared with...
Pfizer Reports Second-Quarter 2008 Results Pfizer Reaffirms Full-Year 2008 Revenue and Adjusted Diluted EPS(1) Guidance; On-Track to Achieve Total Cost-Reduction Target Second-Quarter 2008 Revenues of $12.1 Billion Compared with $11.1 Billion in the Year-Ago Quarter Second-Quarter...
Pfizer Reports Second-Quarter 2008 Results c (NYSE: PFE): ($ in millions, except per share amounts) Second-Quarter Year-to-Date ------------------------ ------------------------ 2008 2007 Change 2008 2007 Change -------- -------- ------ -------- -------- ------ Reported Revenues $ 12...
Pfizer Reports Second-Quarter 2008 Results ($ in millions, except per share amounts) Second-Quarter Year-to-Date ------------------------ ------------------------ 2008 2007 Change 2008 2007 Change -------- -------- ------ -------- -------- ------ Reported Revenues $ 12,129 $ 11,084 9...
Pfizer Reports Second-Quarter 2008 Results - Pfizer Inc (NYSE: PFE): -0- ($ in millions, except per share amounts) Second-Quarter Year-to-Date ------------------------ ------------------------ -------- -------- ------ -------- -------- ------ Reported Revenues $ 12,129 $ 11,084 9% $...
Pfizer Reports Second-Quarter 2008 Results - Pfizer Inc (NYSE: PFE): -0- ($ in millions, except per share amounts) Second-Quarter Year-to-Date ------------------------ ------------------------ -------- -------- ------ -------- -------- ------ Reported Revenues $ 12,129 $ 11,084 9% $...
Pfizer Reports Second-Quarter 2008 Results Pfizer Inc (NYSE: PFE): -0- *T ($ in millions, except per share amounts) Second-Quarter Year-to-Date ------------------------ ------------------------ 2008 2007 Change 2008 2007 Change -------- -------- ------ -------- -------- ------...
Pfizer Reports Second-Quarter 2008 Results -- Pfizer Reaffirms Full-Year 2008 Revenue and Adjusted Diluted EPS(1) Guidance; On-Track to Achieve Total Cost-Reduction Target -- Second-Quarter 2008 Revenues of $12.1 Billion Compared with $11.1 Billion in the Year-Ago Quarter -- Second...
Assess the Impact of Patent Expiry for Lipitor on the Commercial Outlook of Pfizer Over 2006-12 with the 'Pfiz DUBLIN, Ireland-- (BUSINESS WIRE) -- Research and Markets (http://www.researchandmarkets.com/research/fc3743/pfizer_inc_pharm) has announced the addition of the 'Pfizer Inc.: PharmaVitae Profile' company profile to their offering.This...
